Cite
HARVARD Citation
Feng, S. et al. (2018). Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?. Medicine. 97 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feng, S. et al. (2018). Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?. Medicine. 97 (3), p. . [Online].